Literature DB >> 17255838

Influence of different intravenous lipid emulsions on hepatobiliary dysfunction in a rabbit model.

Martina Kohl1, Thilo Wedel, Andreas Entenmann, Julia Stuttmann, Meike Bendiks, Steffan Loff, Stefan Köster, Stefan Ortfeld, Inge Bos.   

Abstract

OBJECTIVES: Long-term total parenteral nutrition (TPN) in children is often complicated by the development of cholestasis, liver fibrosis, and liver failure. High doses of intravenous lipids may be involved in the pathogenesis of hepatobiliary dysfunction. The purpose of this study was to determine whether the use of 2 newly developed lipid emulsions could reduce liver damage.
MATERIALS AND METHODS: Three groups of prepubescent rabbits received TPN including a lipid emulsion either based on soybean oil, olive oil, or soybean oil with n-3 fatty acids added. Enterally fed animals served as controls. After 21 d the animals were killed. Serum samples were obtained at the beginning and end of the study period. Specimens were processed for histological evaluation using a specific score to assess the severity of liver damage.
RESULTS: Biochemical parameters did not predict the extent of liver damage. Hydropic degeneration as an indicator of toxic liver injury was the predominant histological alteration regardless of the type of lipids infused. The extent of fibrosis did not significantly differ among treatment groups except for animals infused with n-3 fatty acids exhibiting increased fibrotic transformation as compared with controls.
CONCLUSION: In our animal model, the use of a lipid emulsion with a reduced amount of polyunsaturated fatty acids was not superior to a lipid emulsion based on soybean oil. Long-term application of n-3 fatty acids was associated with more extensive fibrosis. Therefore, intravenous n-3 fatty acids containing lipid preparations (fish oil) should not be used in patients for long-term TPN.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255838     DOI: 10.1097/01.mpg.0000252193.99331.03

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  6 in total

1.  Omega-3 long chain polyunsaturated Fatty acids for treatment of parenteral nutrition-associated liver disease: a review of the literature.

Authors:  Emma M Tillman; Richard A Helms
Journal:  J Pediatr Pharmacol Ther       Date:  2011-01

Review 2.  Perioperative nutritional support and fluid therapy in patients with liver diseases.

Authors:  Yongliang Sun; Zhiying Yang; Haidong Tan
Journal:  Hepatobiliary Surg Nutr       Date:  2014-06       Impact factor: 7.293

3.  Long-Term Outcomes in Children With Intestinal Failure-Associated Liver Disease Treated With 6 Months of Intravenous Fish Oil Followed by Resumption of Intravenous Soybean Oil.

Authors:  Caroline Wang; Robert S Venick; Stephen B Shew; James C Y Dunn; Laurie Reyen; Rong Gou; Kara L Calkins
Journal:  JPEN J Parenter Enteral Nutr       Date:  2018-11-08       Impact factor: 4.016

4.  Medical and surgical management of the pediatric patient with intestinal failure.

Authors:  Frances R Malone; Simon P Horslen
Journal:  Curr Treat Options Gastroenterol       Date:  2007-10

5.  Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil.

Authors:  Kara L Calkins; James C Y Dunn; Stephen B Shew; Laurie Reyen; Douglas G Farmer; Sherin U Devaskar; Robert S Venick
Journal:  JPEN J Parenter Enteral Nutr       Date:  2013-07-26       Impact factor: 4.016

6.  Histopathologic and electron microscopic investigation of the damage to liver tissue caused by parenteral nutrition combined with starvation in rabbits.

Authors:  Semra Gürünlüoğlu; Mehmet Gül; Harika Gözükara Bağ
Journal:  Clin Exp Hepatol       Date:  2021-05-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.